ScholarGate
Msaidizi

Linganisha mbinu

Pitia mbinu ulizochagua bega kwa bega; safu zinazotofautiana zinaangaziwa.

Njia ya Vigezo vya Ala (IV) kwa Utafutaji wa Kifungo×Mfumo wa Mnyororo wa Markov katika Uchumi wa Afya×
NyanjaUchumi wa AfyaUchumi wa Afya
FamiliaProcess / pipelineProcess / pipeline
Mwaka wa asili1990s (modern applications)1983
MwanzilishiAngrist & Pischke (applied econometrics); rooted in econometric theoryBeck & Pauker (medical decision analysis, Massachusetts General Hospital)
AinaMethodMethod
Chanzo asiliaAngrist, J. D., & Pischke, J. S. (2009). Mostly Harmless Econometrics: An Empiricist's Companion. Princeton: Princeton University Press. link ↗Beck, J. R., & Pauker, S. G. (1983). The Markov Process in Medical Prognosis. Medical Decision Making, 3(4), 419-458. DOI ↗
Majina mbadalaIV, two-stage least squares, TSLS, causal estimationMarkov model, state transition model, cohort simulation
Zinazohusiana35
MuhtasariInstrumental variables (IV) is an econometric method to estimate causal effects when treatment or exposure is not randomly assigned and confounding is severe or unmeasured. IV relies on a third variable (instrument) that influences treatment but does not directly affect the outcome, allowing researchers to isolate the causal effect from the noise of confounding. Developed extensively in econometrics (Angrist & Pischke, 1990s–2000s), IV methods are increasingly used in health economics and health services research to leverage natural experiments and policy changes.A Markov model is a decision-analytic tool that simulates disease progression through defined health states over time, calculating cumulative costs and quality-adjusted life years (QALYs) to enable cost-effectiveness analysis. Developed by Beck and Pauker in 1983, Markov models are now the standard framework for projecting long-term outcomes of health interventions, especially chronic diseases where patients transition between clinical states (treatment response, disease progression, remission, death). Used by health technology assessment bodies and pharmaceutical companies to predict intervention value beyond trial duration.
ScholarGateSeti ya data
  1. v1
  2. 3 Vyanzo
  3. PUBLISHED
  1. v1
  2. 3 Vyanzo
  3. PUBLISHED

Nenda kwenye utafutaji Pakua slaidi

ScholarGateLinganisha mbinu: Instrumental Variables in Health Research · Markov Model in Health Economics. Imepatikana 2026-06-20 kutoka https://scholargate.app/sw/compare